Quent Capital, LLC

Position in OGN — Organon & Co.

CIK 1912338 NEW YORK, NY

Position in OGN

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$5,578

-$25,204 QoQ

Shares Held

412

-92.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#365

of 626 holders

Holding Since

Dec 2021

18 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Quent Capital, LLC holds $16,590,775 across 15 Drug Manufacturers - General names. OGN ranks #14 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	5,433	$6,516,503
2	JNJ	Johnson & Johnson	10,802	$2,743,383
3	ABBV	AbbVie Inc.	9,570	$2,408,194
4	AMGN	Amgen Inc	6,535	$2,366,454
5	MRK	Merck & Co., Inc.	9,312	$1,196,592
6	GILD	Gilead Sciences, Inc.	3,680	$464,931
7	PFE	Pfizer Inc	15,327	$369,074
8	GSK	GSK plc	3,314	$173,719

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,578	412	-92.0%	Shares	Sole	2026-08-07
2026-03-31	$30,782	5,139	+3883.7%	Shares	Sole	2026-04-28
2025-12-31	$924	129	-88.2%	Shares	Sole	2026-01-29
2025-09-30	$11,630	1,089	+33.1%	Shares	Sole	2025-10-27
2025-03-31	$12,180	818	+10.4%	Shares	Sole	2025-04-04
2024-12-31	$11,055	741	-15.6%	Shares	Sole	2025-01-29
2024-09-30	$16,796	878	+10.4%	Shares	Sole	2024-10-04
2024-06-30	$16,456	795	-8.0%	Shares	Sole	2024-07-08
2024-03-31	$16,243	864	-0.7%	Shares	Sole	2024-06-28
2023-12-31	$12,545	870	+76.1%	Shares	Sole	2024-06-17
2023-09-30	$8,575	494	-37.3%	Shares	Sole	2024-06-17
2023-06-30	$16,398	788	+0.1%	Shares	Sole	2024-06-17
2023-03-31	$18,510	787	+4.1%	Shares	Sole	2024-06-17
2022-12-31	$21,115	756	-49.1%	Shares	Sole	2023-01-19
2022-09-30	$34,725	1,484	+1.1%	Shares	Sole	2022-11-10
2022-06-30	$49,545	1,468	-0.7%	Shares	Sole	2022-08-08
2022-03-31	$51,661	1,479	-16.5%	Shares	Sole	2022-05-12
2021-12-31	$53,926	1,771	—	Shares	Sole	2022-05-12
No filing history on record for this holder in this stock.